CPL207280, an orally active GPR40/FFA1 agonist with antidiabetic effects, enhances glucose-stimulated insulin secretion and improves glucose tolerance in MIN6 pancreatic beta-cells, healthy Wistar Han rats, and diabetic rat models, making it a valuable compound for type 2 diabetes research [1] [2].
Molecular Weight:
286.37
CAS Number:
[2361497-72-3]
Formula:
C18H22O3
Target:
GPCR
T86087
* VAT and and shipping costs not included. Errors and price changes excepted
